Saturday, October 26, 2024
HomeTagsNeuropsychiatric Target Discovery

Neuropsychiatric Target Discovery

AbbVie and Gedeon Richter Collaborate on Neuropsychiatric Target Discovery

AbbVie and Gedeon Richter Plc. ('Richter') announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics